Nerlynx

E2190193 UNEXPLORED

Nerlynx is an oral targeted cancer therapy used primarily to treat HER2-positive breast cancer by irreversibly inhibiting the HER2 receptor tyrosine kinase.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
Nerlynx canonical	1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

neratinib → hasUSBrandName → Nerlynx ⓘ